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SUMMARY – Th e aim of the study was to analyze postural stability, walking speed and fear of 
falling in patients with diabetic polyneuropathy (DPN) in order to determine the risk factors for falls, 
as well as the eff ect of DPN characteristics as additional factors. A sample of 48 patients with type 2 
diabetes and DPN were enrolled in this non-randomized observational study. Th e patients were di-
vided into two groups of fallers and non-fallers. All subjects underwent evaluation with the Func-
tional Reach Test (FRT), Tinetti Falls Effi  cacy Scale (Tinetti FES) and 10-Meter Walk Test 
(10MWT). Neuropathy was quantifi ed with the Michigan Neuropathy Screening Instrument (MNSI, 
Questionnaire part) and 5.07/10-g Semmes Weinstein monofi lament examination (SW-ME). Th e 
10MWT and SW-ME were signifi cantly diff erent between the faller and non-faller groups (p<0.05). 
Duration of DPN correlated positively with SW-ME (p=0.005) in the faller group. FES showed 
signifi cant positive correlation with MNSI and negative correlation with 10MWT in the non-faller 
group. Logistic regression analysis revealed that SW-ME was signifi cantly associated with the prob-
ability of falling (p=0.0076; OR=1.378). Study results suggested that the loss of protective sensitivity 
of foot could be a risk factor for falls in people suff ering from type 2 diabetes.
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Introduction
Th e causes of falls are multifactorial in people with 
diabetes1. Th e annual incidence rate of falls in people 
with diabetes older than 55 is 35% and in those over 
65 it is 39%2,3. An important potential risk factor for 
falls is diabetic polyneuropathy (DPN), which is pres-
ent in half of people with diabetes4. In 2008, a report 
by the Quality Standards Subcommittee of the Amer-
ican Academy of Neurology indicated that people 
with peripheral neuropathy had a probable (level B 
evidence) risk of fall5. Diff erent possible risk factors 
that can cause fall in people with diabetes and DPN 
have been examined so far. Th e problem of balance in 
elderly people with type 2 diabetes has often been re-
ported as a signifi cant risk2. In addition to reduced 
proprioceptive inputs, neuropathic symptoms also play 
a role in the decrease of walking speed. Balance prob-
lems are also caused by biomechanical structural disor-
ders, limited joint mobility and distal weakness6,7. In 
previous studies, the reduced sensitivity of foot and 
pain were the risk factors of diabetic foot, but there are 
not enough data to prove that these symptoms predict 
falls in people with diabetes. Examination of lower 
limb usually shows sensory loss of vibration, pressure, 
pain, and temperature perception (mediated by small 
and large fi bers) and absent ankle refl exes8.
People with DPN have a reduced walking speed, as 
well as other gait alterations6,9. Somatosensory losses 
in legs compromise the functional postural stability 
and lead to the risk of falling when performing more 
demanding daily activities9. From the aspect of reha-
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bilitation, accurate assessment of balance and dysfunc-
tion at walk is important in order to plan the program 
of exercises9. Chau et al. believe that there is a need of 
forming subgroups of people with diabetes in order to 
determine a special program of exercises. Th e reason 
for this suggestion is the existence of multisystemic 
impairment in DPN, which can be the cause of fall in 
people with diabetes10. Jernigan et al.11 point to the 
conclusion of a recent systematic literature review that 
there is a need of research in this area of exercise ap-
plication in order to prevent falls.
A possible selection of tests to assess balance and 
stability is suggested in the monographs issued by 
members of the European Academy of Rehabilitation 
Medicine12 with the aim to identify whether or not a 
problem exists in order to predict the risk of fall and to 
determine whether treatment is needed or has been 
eff ective.
When setting up a goal, we assumed that in the 
group of people younger than 70 we reduce the possi-
ble changes caused by the aging process, which in the 
interaction with DPN, could aff ect the result13.
Th e aim of this study was to analyze postural sta-
bility, walking speed and fear of falling to determine 
predictors of falls in a group of patients with DPN, as 
well as the impact of DPN characteristics as con-
founding factors.
Patients and Methods
Th e study was approved by the Ethics Committee 
of the Clinical Center of Montenegro. An informed 
consent was obtained from all study participants.
Patients
Th e study included a group of 48 patients with type 
2 diabetes with electromygraphically confi rmed DPN, 
between 35 and 70 years of age, who were referred for 
outpatient examination at the Center for Physical 
Medicine and Rehabilitation, Clinical Center of Mon-
tenegro in the period from January 2015 to January 
2016. Patient data were obtained from medical docu-
mentation. Data on diabetes duration and duration of 
DPN were collected from endocrinologist and neu-
rologist documentation. Glycosylated hemoglobin 
(HbA1c) was determined within two months. Exclu-
sion criteria were age >70, lack of blood sugar control, 
amputation of foot, musculoskeletal disease, injury 
that could infl uence functionality, neurologic and car-
diovascular disease, and use of medications that poten-
tially can aff ect the activities of daily living.
Fall history
Th e patients were asked whether they had sus-
tained a fall in the last three years. Study patients were 
divided according to the history of falls into two 
groups: non-faller (0 fall in the previous three years) 
and faller (1 or more falls in the previous three years).
Fall risk assessment
Functional Reach Test (FRT) was selected because 
it measures some degree of static or dynamic balance 
and is easily administered in a clinical setting. It is 
based on analyzing the limits of stability in the ab-
sence of external shocks, assessing maximum displace-
ment, intentionally, which can reach a subject without 
losing balance14. Instructions are available at the Reha-
bilitation Measures Database15. Tinetti Falls Effi  cacy 
Scale (Tinetti FES) was selected to assess perception 
of balance and stability during activities of daily living. 
A 10-item questionnaire is so designed to reveal con-
fi dence in their ability to perform 10 daily tasks with-
out falling as an indicator of how one’s fear of falling 
impacts physical performance. Each item is rated from 
1 (“very confi dent”) to 10 (“not confi dent at all”), and 
per item ratings are added to generate a summary total 
score. Total scores can range from 10 (best possible) to 
100 (worst possible). Th us, lower scores indicate more 
confi dence and higher scores indicate lack of confi -
dence and greater fear of falling. Functional mobility 
was evaluated by using the 10-Meter Walk Test 
(10MWT). Th e aim was to collect results from three 
trials and calculate the mean of these three trials.
Examination of neuropathy
All patients were evaluated with the Michigan 
Neuropathy Screening Instrument (MNSI, Question-
naire part)16. Th e MNSI is an instrument including a 
questionnaire with 15 questions, with a maximum 
score of 13. Th e questionnaire asks about positive 
(pain, temperature sensation, tingling) and negative 
(numbness) sensory symptoms, cramps and muscle 
weakness, foot ulcers or cracks, and amputation. Neu-
ropathy can be defi ned as seven or more positive re-
sponses on the MNSI questionnaire17. Monofi lament 
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sensation was tested with the 5.07/10-g Semmes 
Weinstein monofi lament examination (SW-ME) ap-
plied to ten sites per foot. Nine plantar sites (distal 
great toe, third toe, and fi fth toe; fi rst, third, and fi fth 
metatarsal heads; medial foot, lateral foot, and heel) 
and one dorsal site were tested. Th e examiner had no 
information on other results, testing was repeated 
twice, and the results were estimated with a cut-off  of 
more than 4 sites for the loss of protective sensitivity.
Statistical analysis
On statistical analysis we used EZR software. Co-
effi  cient of variation and quantile-quantile comparison 
(QQ) plot were used to assess normal distribution 
compatibility. Mann Whitney test was used to exam-
ine diff erence in age, duration of diabetes, DPN dura-
tion, Tinetti FES, MNSI, 10MWT and SW-ME, and 
two-sample t test for diff erence in HbA1c and body 
mass index (BMI) between the non-faller and faller 
groups. Spearman’s rank correlation test was used for 
analysis of correlation between DPN duration and 
SW-ME, Tinneti FES and MNSI, Tinneti FES and 
10MWT. Logistic regression analysis was performed 
in order to analyze the relationship between SW-ME 
and risk of falling. Th e level of statistical signifi cance 
was set at p<0.05.
Results
Patient demographic and clinical data are shown in 
Table 1. Th ere were no signifi cant diff erences between 
the faller and non-faller groups in respect of age, gen-
der, HbA1c and BMI. Duration of diabetes and dura-
tion of confi rmed DPN were signifi cantly diff erent 
between the two groups (p<0.05). In the assessment 
of the risk of falling, 10MWTand SW-ME were sig-
nifi cantly diff erent between the faller and non-faller 
groups (p<0.05).
Analysis of results in the faller group
During the three-year period, 28 participants re-
ported a fall: 14 participants reported one fall; 7 par-
ticipants reported two falls; and 7 participants reported 
three and more falls. Th e median DM duration was 11 
(range 5-27) years and duration of DPN confi rmed by 
neurology was 6 (range 1-15) years. Th e evidence for 
fear of falling measured by Tinetti FES score was 
higher in the faller group (23, range 12-51) than in the 
Table 1.Comparison of characteristics between faller and non-faller groups 
Faller (n=28) Non-faller (n=20)




Age (yrs) 63.5 37-70 65 57-70 0.6128
BMI (kg/m2) 25.53±2.92 26.82±3.07 0.148
Diabetes duration (yrs) 11 5-27 7.5 2-15 0.0024*
Duration of non-
-confi rmed DPN (yrs)
Duration of confi rmed 
DPN (yrs)
6 1-15 3 1-15 0.0487*
HbA1c % 6.52±0.72 6.70±0.67 0.3873
MNSI 8 4-11 6.5 3-13 0.1099
Tinetti FES 23 12-51 18 10-51 0.0638
10MWT (m/s) 0.950 0.58-1.49 1.185 0.65-1.85 0.0238*
FRT(cm) 25.38±8.13 25.10±6.14 0.8965
SW-ME 4.5 0-10 1.5 0-8 0.0101*
BMI = body mass index; DPN = diabetic polyneuropathy; MNSI = Michigan Neuropathy Screening Instrument; Tinetti FES = Tinetti 
Falls Effi  cacy Scale; 10MWT = 10-Meter Walk Test; FRT = Functional Reach Test; SW-ME = 5.07/10-g Semmes Weinstein monofi la-
ment examination; *p<0.05
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non-faller group (18, range 10-51). Th e walking speed 
measured by 10MWT was signifi cantly lower in the 
faller group as compared with the non-faller group 
(0.950, range 0.58-1.49; p<0.05). Th e mean value of 
FRT was 25.38 (SD 8.12).
Testing of the absence of protective sensitivity 
(SW-ME) showed the median in patients with a his-
tory of falling to be signifi cantly higher (4.5, range 
0-10) as compared with the non-faller group (1.5, 
range 0-8; p<0.05).
Signifi cant correlations within groups
In the faller group, signifi cant correlation was 
found between DPN symptom duration and SW-ME 
Fig. 1. Correlation between duration of diabetic 
polyneuropathy (DPN) and 5.07/10-g Semmes 
Weinstein monofi lament examination (SW-ME) 
testing in the faller group.
Fig. 2. Correlation between Michigan Neuropathy 
Screening Instrument (MNSI) and Tinetti Falls 
Effi  cacy Scale (FES) in the non-faller group.
Fig. 3. Correlation between Tinetti Falls Effi  cacy Scale 
(FES) and 10-Meter Walk Test (10MWT) 
in the non-faller group.
Fig. 4. Th e output indicates that monofi lament 
is signifi cantly associated with the probability of falling 
(p=0.0076 Wald test); odds ratio unit change is equal 
to 1.378.
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testing (S=1787.5, Spearman’s rank correlation coeffi  -
cient 0.511; p=0.00548) (Fig. 1). Th ere was signifi cant 
correlation between Tinetti FES and MNSI in the 
non-faller group (S=594.2, Spearman’s rank correla-
tion coeffi  cient 0.553; p=0.0114) (Fig. 2). In the non-
faller group, signifi cant negative correlation was re-
corded between FES and 10MWT (S=1986.9, Spear-
man’s rank correlation coeffi  cient -0.494; p=0.0269) 
(Fig. 3). SW-ME was examined by logistic regression: 
the output indicated that monofi lament was signifi -
cantly associated with the probability of falling 
(p=0.0076, Wald test). Odds ratio unit change was 
equal to 1.378 (Fig. 4).
Discussion
We examined the association between DPN and 
risk of falls. In order to implement programs for the 
prevention of falls, it is necessary to identify the risk, 
taking into account that falling is a complex and mul-
tifaceted issue. One group of our patients had prob-
lems with postural control according to the results of 
FRT compared to the cut-off  score. Since balance con-
trol is a complex entity, it is diffi  cult for a single test to 
measure all its aspects. Jonsson et al.18 suggest that it is 
important to specify what aspect of balance the test 
measures and to validate that the test really does refl ect 
this aspect.
In our study, walking speed proved to be a signifi -
cant characteristic that aff ects safety in performing the 
given daily activities. Walking speed was signifi cantly 
lower in the participants with the history of fall. Mea-
suring of walking speed in patients with DPN is sig-
nifi cant because walking capacity and performance are 
decreased in patients with diabetic complications of 
the foot19. Kanade et al.19 suggest that decreased walk-
ing speed in patients with DPN matches with reduced 
plantar pressures at some sites on the foot. When it 
comes to exercise programs, Allet et al. applied exercise 
program based on the program of prevention of falls in 
the elderly population in order to improve walking 
speed and balance in people with diabetes4. Cummn-
ing et al. consider that “fear of falling” as a medical 
problem is as important in the group of non-fallers as 
in the group of fallers20. In our study patients, Tinetti 
FES showed higher values in the group of fallers but 
there was no correlation with other variables exam-
ined. In patients who had no experience of falling 
(non-faller group), the expression of fear of falling was 
associated with decreased walking speed. In the same 
group, increasing the fear of falling correlated with the 
higher score of neuropathic symptoms, suggesting that 
the expression of the fear of falling is a signifi cant 
problem in patients with DPN. Our study subjects had 
long-term duration of diabetes and DPN, which was 
signifi cantly longer in the faller group. Analyzing pain 
in our study participants, the results of MNSI showed 
that the presence of pain had high scores, but they 
were higher in the group of fallers. Neuropathic symp-
toms can be “totally silent”21 or numbness, burning 
foot pain is more pronounced at night, and can be 
present at the time of diabetes diagnosis or a few years 
later. Our results showed that in the group of fallers 
there was a correlation between the duration of DPN 
symptoms and loss of foot sensitivity. Evaluation of 
protective sensitivity by monofi lament testing was the 
subject of examination in a great number of studies22-25. 
In our study, this testing revealed that less than half of 
the participants in the faller group had insensitivity in 
more than four examined points on their feet. Arm-
strong et al.25 consider that identifi cation of more than 
four points is of high sensitivity for detection of pa-
tients with a risk of complications of neuropathy in 
people with diabetes. A positive odds ratio of 1.378 in 
this study showed that increase in the number of in-
sensitive points on the foot increased the possibility of 
falling.
Th is study demonstrated the need for using tests 
for the risk of falls in patients with DPN and sug-
gested that DPN is a specifi c entity for planning spe-
cifi c prevention programs of physical therapy and re-
habilitation. A limitation of this study was a small 
number of patients.
Conclusion
We found a decrease in walking speed to be an im-
portant complication that could infl uence falling in 
patients with DPN. In patients who have no experi-
ence of falling, fear of falling increases with decreasing 
walking speed. Furthermore, the study suggested that 
a signifi cant predictive factor for the risk of falling is 
the lack of protective sensitivity of the foot, which is 
associated with the duration of DPN.
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Sažetak
DIJABETIČKA POLINEUROPATIJA I RIZIK OD PADA: 
STRAH OD PADA I DRUGI ČIMBENICI
V. Bokan-Mirković, Ž. Škarić-Karanikić, S. Nejkov, M. Vuković i D. Ćirović
Cilj ovoga rada bio je analizirati posturalnu stabilnost, brzinu hoda i strah od pada u bolesnika s dijabetičkom polineuro-
patijom (DPN) kako bi se utvrdili rizični čimbenici za padove, kao i utjecaj karakteristika DPN kao dodatnih čimbenika. 
Uzorak od 48 bolesnika s dijabetesom tipa 2 i DPN uključen je u ne-randomiziranu opservacijsku studiju. Sudionici su 
 podijeljeni u dvije skupine: skloni padovima (faller) i neskloni padovima (non-faller). Svi ispitanici su podvrgnuti ocjeni 
 pomoću sljedećih testova: Functional Reach Test (FRT), Tinetti Falls Effi  cacy Scale (Tinetti FES) i 10-Meter Walk Test 
(10MWT). Neuropatija je kvantifi cirana pomoću Michigan Neuropathy Screening Instrument (MNSI) (Upitnik-dio) i testa 
5,07/10-g Semmes Weinstein monofi lament (SW-ME). Rezultati na 10 MWT i SW-ME su bili značajno različiti između 
skupina bolesnika sklonih padovima i onih nesklonih padovima (p<0,05). Trajanje DPN bilo je pozitivno povezano sa 
 SW-ME (p=0,005) u skupini bolesnika sklonih padovima. Ljestvica FES je značajno pozitivno korelirala s MNSI i negativ-
no s 10MWT u skupini bolesnika nesklonih padovima. Logistička regresijska analiza je pokazala da je SW-ME značajno 
povezana s vjerojatnošću pada (p=0,0076; OR=1,378). Studija je ukazala na to da je gubitak zaštitne osjetljivosti stopala 
značajan čimbenik za pad kod osoba koje pate od dijabetesa tipa 2.
Ključne riječi: Dijabetes melitus; Dijabetičke neuropatije; Rizik; Nesretni padovi; Posturalna ravnoteža
